We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

5 hedge funds and large institutions have $0 invested in PDL BioPharma, Inc. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% less funds holding

Funds holding: 8 → 5 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less capital invested

Capital invested by funds: $41.1M → $0 (-$41.1M)

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$40.9M
2
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado
Colorado
-$141K
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$83K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
– -$40.9M -14,397,212 Closed
Public Employees Retirement Association of Colorado
2
Public Employees Retirement Association of Colorado
Colorado
– -$141K -57,000 Closed
Tudor Investment Corp
3
Tudor Investment Corp
Connecticut
– -$83K -33,559 Closed

PDLI Hedge Fund Activity: Q4 2021 in Review

5 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2021, worth a combined $0 — down 100% from $41.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PDLI and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Park West Asset Management, exiting entirely with an estimated $40.9M sold.

  • 5 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2021, down from 8 in Q3 2021.
  • Funds reported $0 of PDL BioPharma, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 1 fund opened new PDL BioPharma, Inc. positions in Q4 2021 and 4 closed out, a net change of -3 holders.
  • The largest PDL BioPharma, Inc. seller in Q4 2021 was Park West Asset Management, an estimated $40.9M sold.

Based on aggregated 13F filings for Q4 2021.